ACRS
Aclaris Therapeutics Inc
3.40$
-8.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | 66.2% | 75.5% | 86.5% | 32.1% | 73.3% | 95.6% | 55.1% | 46.1% | 84.0% | 93.8% | 90.2% | 67.9% | 82.1% | 81.4% | 67.6% | 69.2% | 66.2% | 76.5% | 79.5% | 69.9% | 43.2% | 19.5% | 73.9% | 85.2% | 88.3% | 36.6% | 76.7% | 69.0% | 55.4% | 101.0% | 34.8% | 104.1% | 16.3% | -62.0% | 19.8% | 14.2% | 4.4% | |
| – | – | – | – | 33.8% | 24.5% | 13.5% | 67.9% | 26.7% | 4.4% | 44.9% | 53.9% | 16.0% | 6.2% | 9.8% | 32.1% | 17.9% | 18.6% | 32.4% | 30.8% | 33.8% | 23.5% | 20.5% | 30.1% | 56.8% | 80.5% | 26.1% | 14.8% | 11.7% | 63.4% | 23.3% | 31.0% | 44.6% | -1.0% | 65.2% | -4.1% | 83.7% | 162.0% | 80.2% | 85.8% | 95.6% | |
| – | – | – | – | 1,588.3% | 1,320.2% | 1,217.0% | 380.4% | 978.6% | 532.5% | 395.1% | 300.5% | 1,646.3% | 1,056.2% | 545.6% | 316.0% | 430.6% | 566.8% | 441.1% | 432.9% | 842.4% | 939.5% | 984.6% | 1,229.0% | 124.4% | 271.8% | 893.5% | 1,352.3% | 257.2% | 151.7% | 410.6% | 316.7% | 137.0% | 98.0% | 796.2% | 644.3% | 394.9% | 1,280.6% | 784.4% | 1,157.2% | 780.1% | |
| – | – | – | – | 667.5% | 541.1% | 559.9% | 180.1% | 403.8% | 182.4% | 162.5% | 136.2% | 628.1% | 599.6% | 440.7% | 272.3% | 266.3% | 310.1% | 271.6% | 321.8% | 360.4% | 462.6% | 419.8% | 397.6% | 30.6% | 92.2% | 347.7% | 390.4% | 73.2% | 46.8% | 285.4% | 171.8% | 130.1% | 53.8% | 421.9% | 303.1% | 147.7% | 430.6% | 337.8% | 371.3% | 282.7% | |
| – | – | – | – | 2,775.9% | 2,571.3% | 2,781.7% | 897.0% | 2,081.4% | 1,068.4% | 785.5% | 587.4% | 2,285.8% | 1,609.2% | 1,111.9% | 588.4% | 740.2% | 876.8% | 1,637.8% | 1,017.9% | 1,257.1% | 1,548.6% | 1,321.7% | 1,404.1% | 166.5% | 455.5% | 1,209.5% | 1,717.1% | 351.9% | 86.4% | 812.7% | 495.7% | 285.5% | 1,081.2% | 1,308.1% | 1,031.8% | 603.5% | 1,917.5% | 1,192.0% | 1,573.7% | 1,145.8% | |
| – | – | – | – | -2,742.1% | -2,546.7% | -2,768.2% | -869.9% | -2,054.7% | -1,064.0% | -740.6% | -849.0% | -2,325.9% | -1,603.0% | -1,102.1% | -556.3% | -722.2% | -858.2% | -1,605.5% | -987.2% | -1,223.3% | -1,525.2% | -1,301.2% | -1,374.0% | -109.8% | -375.1% | -1,183.5% | -1,702.2% | -340.2% | -23.0% | -789.4% | -464.7% | -240.9% | -1,082.1% | -1,242.9% | -1,035.9% | -519.8% | -1,755.5% | -1,111.8% | -1,487.9% | -1,050.2% | |
| – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | – | – | – | 82.6% | 222.5% | 11.6% | 89.1% | 63.3% | – | – | 9.1% | – | – | – | 44.4% | – | – | – | – | – | – | – | |
| – | – | – | – | -2,659.6% | -2,478.9% | -2,703.8% | -849.2% | -2,011.1% | -1,050.7% | -745.2% | -850.4% | -2,353.8% | -1,776.1% | -1,089.4% | -565.5% | -735.6% | -872.1% | -1,618.1% | -995.7% | -1,274.6% | -1,519.3% | -1,293.1% | -1,343.7% | -104.9% | -356.4% | -1,113.9% | -1,582.1% | -315.2% | -10.6% | -706.5% | -397.2% | -174.6% | -1,048.2% | -1,036.8% | -868.3% | -443.0% | -1,528.6% | -993.2% | -1,320.1% | -921.5% | |
| – | – | – | – | 0.0% | -183.2% | -163.7% | 40.8% | 0.0% | -26.1% | – | 315.5% | 3,329.9% | -2,938.9% | -22.6% | 1.3% | -40.8% | -11.5% | 925.1% | 263.2% | 54.2% | 133.4% | -90.7% | -252.7% | 6.7% | 73.0% | -69.5% | -80.3% | -2.4% | -2.1% | 8.3% | – | -174.6% | – | – | – | – | – | – | – | – | |
| – | – | – | – | -2,659.6% | -2,295.7% | -2,703.8% | -849.2% | -2,011.1% | -1,050.7% | -745.2% | -850.4% | -5,627.6% | -1,698.1% | -1,107.7% | -566.8% | -735.6% | -833.7% | -1,618.1% | -995.7% | -1,274.6% | -1,519.3% | -1,293.1% | -1,343.7% | -104.9% | -356.4% | -1,113.9% | -1,582.1% | -315.2% | -8.5% | -706.5% | -397.2% | -174.6% | -1,048.2% | -1,036.8% | -868.3% | -443.0% | -1,528.6% | -993.2% | -1,320.1% | -921.5% | |
| – | – | – | – | -2,725.1% | -2,501.0% | -2,768.2% | -840.7% | -1,297.2% | -1,024.6% | -492.5% | -378.9% | -2,159.9% | -1,624.2% | -935.5% | -526.6% | -638.2% | -858.2% | -664.2% | -710.5% | -1,157.6% | -1,365.5% | -1,369.5% | -1,583.0% | -97.2% | -281.0% | -1,207.3% | -1,716.2% | -316.4% | -134.3% | -662.6% | -456.0% | -218.4% | -151.2% | -1,213.5% | -945.1% | -436.6% | -1,520.7% | -988.1% | -1,307.3% | -913.9% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.